Scientists at Houston Methodist Hospital developed the intelligent-augmented breast cancer risk calculator, testing it across a large dataset to produce promising results. 

Given the approach’s “superior prognostic value,” experts urged for the incorporation of tau PET into routine clinical evaluation in memory care clinics. 

Scientists believe this is the first series demonstrating a significant survival difference in patients monitored with an intensive follow-up strategy via 18F-fludeoxyglucose–positron emission tomography.  

The contrast agent, simply called Gadobutrol Injection, has been approved by the U.S. Food and Drug Administration and is now available in the United States.

A new AI model helped researchers identify a relationship between background parenchyma enhancement on breast MRI exams and breast cancer risk.

“While drug pricing is not opaque and absolute costs of medications can vary widely, any waste comes at a cost," researchers wrote in a new analysis. 

It may be necessary to monitor physicians' average daily productivity numbers over more extended periods of time to address this issue. 

“Until there is a global consensus on how this is regulated, Asian countries—where data privacy is less of a focus—could see a clear contrast with the West in how AI is used.”

The problem of commercial health insurers standing between patients and providers is bad and only getting worse.